Banzai International, Inc. (NASDAQ:BNZI – Get Free Report) was the target of a large growth in short interest in November. As of November 30th, there was short interest totalling 180,600 shares, a growth of 44.1% from the November 15th total of 125,300 shares. Approximately 5.9% of the shares of the stock are sold short. Based on an average daily trading volume, of 4,100,000 shares, the days-to-cover ratio is presently 0.0 days.
Wall Street Analyst Weigh In
Separately, Ascendiant Capital Markets dropped their price objective on shares of Banzai International from $162.50 to $125.00 and set a “buy” rating for the company in a research note on Thursday, August 29th.
Check Out Our Latest Stock Report on BNZI
Insider Buying and Selling at Banzai International
Banzai International Stock Performance
Shares of NASDAQ:BNZI traded down $0.11 during trading on Friday, reaching $1.47. 383,791 shares of the company were exchanged, compared to its average volume of 1,151,483. The business’s fifty day simple moving average is $2.32 and its 200-day simple moving average is $5.22. Banzai International has a 12-month low of $1.30 and a 12-month high of $828.50.
About Banzai International
Banzai International, Inc, a marketing technology company, provides data-driven marketing and sales solutions for various businesses in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its products include Demio, a browser-based webinar platform with data and marketing features designed to help businesses engage with their audience through live events and on-demand, interactive video content; Boost, a software-as-a-service (SaaS) solution for social sharing by event registrants; and Reach, a SaaS and managed service to increase registration and attendance of marketing events.
Featured Articles
- Five stocks we like better than Banzai International
- Why Invest in 5G? How to Invest in 5G Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Stock Analyst Ratings and Canadian Analyst Ratings
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Banzai International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Banzai International and related companies with MarketBeat.com's FREE daily email newsletter.